NEA Partners 15, L.P.
CIK 1640031 · last filed 2022-12-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AVEO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 600
TIMONIUM, MD 21093
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 4,745,262 | $115.07 | $546.04M | $0 | 1 | 2022-12-22 |
| IONQ.WS | 10%+ Owner | 14,790,207 | $33.55 | $496.21M | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 59,294 | $15.00 | $889.4K | $39.07M | 4 | 2022-10-21 |
| HOOD | Director | 43,588,345 | $101.93 | $4.44B | $0 | 3 | 2022-02-01 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 226,001 | $2.57 | $580.8K | $16.80M | 2 | 2021-05-26 |
| NKTX | 10%+ Owner | 2,235,449 | $1.75 | $3.91M | $36.00M | 1 | 2020-07-16 |
Recent Filings · Page 2 of 2
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-10 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +283,492 | $605.0K | EDGAR |
| 2018-04-10 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +3,683,904 | $8.46M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.